Dash Pharmaceuticals LLC has recalled approximately 45,940 unit dose cups of Sucralfate Oral Suspension, USP 1g/10mL, a prescription medication used to treat intestinal ulcers. The recall was initiated due to a labeling mix-up that may result in incorrect medication identification or dosage instructions. No injuries or incidents have been reported, but consumers should contact their healthcare provider or pharmacist if they have used the affected product.
A labeling mix-up poses a risk that patients may receive the wrong medication or incorrect dosage instructions, which could lead to ineffective treatment of ulcers or unexpected side effects.
You have 2 options:
Packaged in cases of 40.
Packaged in cases of 100.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.